Lung Prediction Panel
Predict genomic alterations in NSCLC samples
in minutes with an AI-powered assay
Lung Prediction Panel is an AI-powered research-use assay built on the CanvOI foundation model. It predicts the presence of eight genomic alteration biomarkers in NSCLC from H&E whole-slide images and provides results in minutes.
The RUO panel includes EGFR, KRAS G12C, ERBB2, and BRAF V600E mutations; ALK, RET, and ROS1 fusions; and MET exon 14 skipping.
Results can support sample prioritization across a variety of research use applications including retrospective studies, tissue stewardship, and biomarker analysis.
This RUO product is not for clinical use. Please visit the OI Predict page to learn more about our clinical services and our Laboratory Developed Test (LDT).
How it Works
Upload WSI and perform QC
Following image upload, a quality control step ensures tissue integrity and quantity of analyzable tissue.
Rapid multi-gene AI analysis
Rapid analysis across all eight biomarkers in a single H&E-based workflow.
Exploratory biomarker data review
Review visual patterns, histological feature summaries, and heatmaps.
Research Evaluation
Lung Prediction Panel has been evaluated in internal and external retrospective research studies, including academic and biopharma collaborations.
Contact Imagene to learn more about our completed and ongoing research programs.
In prescreening workflows, the panel can prioritize samples for confirmatory molecular testing. Confirmatory testing is required to determine trial eligibility.
Prioritize samples for molecular confirmation in-house
Lung Prediction Panel
is Powered by
Our state-of-the-art Oncology Intelligence foundation model co-developed with Oracle and trained on more than 2 million H&E and IHC images across 40+ organs and tissue types.
When benchmarked against publicly available foundation models, CanvOI achieved up to 20% higher performance in low-data settings.
Our most commonly asked questions
How has Lung Prediction Panel been evaluated?
Lung Prediction Panel has been assessed in internal and external research settings in academia and biopharma. Select classifiers early in development were additionally evaluated in npj Precision Oncology. Contact Imagene to review available study details.
Does Imagene develop custom models for other use cases?
Yes. Through OI Profile, Imagene develops custom models for research applications across multiple tissue types. The breadth and depth of the CanvOI foundation model support algorithm development for diverse research applications. Contact Imagene to discuss a pilot study.
Can Lung Prediction Panel be used for clinical diagnostics?
No. Lung Prediction Panel is For Research Use Only. Not for use in diagnostic procedures. Results must not be used to diagnose disease, guide treatment, make patient-management decisions, or determine clinical-trial eligibility.
For information about Imagene’s separate clinical offerings, contact us or visit the LungOI webpage.
Why Imagene AI?
Imagene develops AI-powered pathology tools for research and, separately, supports clinical laboratory offerings through a CAP-accredited, CLIA-certified laboratory. Lung Prediction Panel is not part of those clinical offerings and remains For Research Use Only.